.ORG Impact Award Supporting Materials


The World Ovarian Cancer Coalition is the only global advocacy organisation focussed on ovarian cancer. The Coalition is a global network of close to 200 partner organisations and growing. This resource page is dedicated to supporting the World Ovarian Cancer Coalition’s application for .ORG Impact Awards in the Equity, Diversity, and Inclusion category. The materials below reflect the impactful work and transformative change the World Ovarian Cancer Coalition is driving to get closer to #NoWomanLeftBehind.

2023-2028 Strategy

Developed by an expanded Board of Directors with representation from the UK, Canada, Germany, Australia, Bangladesh, and Nigeria, the World Ovarian Cancer Coalition’s Strategic Plan for 2023-2028 outlines a comprehensive approach to making ovarian cancer a global priority. This plan emphasizes the Coalition’s commitment to driving profound and equitable change for all those impacted by ovarian cancer through partnerships, evidence-based advocacy, and awareness initiatives. The strategy aims to improve prevention, diagnosis, treatment, and quality of life for patients worldwide. Key goals include increasing access to rapid diagnosis and the best treatments, enhancing awareness and health literacy, and utilizing data to inform global policies. This strategic framework underscores the Coalition’s vision of ensuring everyone at risk of or living with ovarian cancer has the best chance of survival and quality of life, regardless of their location. For more details, please refer to the full strategic plan.

From Evidence to ActionOur 5-Year Strategy

Every Woman Study™: Low- and Middle-Income Edition

The Every Woman Study™: Low- and Middle-Income Edition, a collaboration between the World Ovarian Cancer Coalition and the International Gynecologic Cancer Society (IGCS), has reached a critical stage. With participation from 2,446 women in 82 hospitals across 22 countries, this study aims to improve ovarian cancer outcomes in resource-limited settings. Data collection ended in April 2024, and our main analysis is now underway. The initial findings will be shared in upcoming papers and conferences, including the ESMO Gynaecology Conference, ESMO Congress, and London Global Cancer Week. As a result of this, and other work that the Coalition is undertaking, a third of new partner organisation applications now come from LMIC. For more information on this groundbreaking study visit the link below. You can also watch a clip from the Clinical Lead in Nigeria, Dr. Aisha Mustapha, as she expresses her hopes and excitement at participating in this Study.

Every Woman Study™ 2024

NICRAT Memorandum of Understanding

The World Ovarian Cancer Coalition, in collaboration with the Nigerian Institute for Cancer Research and Treatment (NICRAT), has embarked on a significant partnership aimed at improving outcomes for women with ovarian and other gynecological cancers in Nigeria. This initiative highlights the Coalition’s dedication to Diversity, Equity, and Inclusion, bringing together a diverse group of stakeholders—including patients, advocacy organizations, healthcare professionals, researchers, and policymakers—to address the critical challenges of cancer prevention, diagnosis, treatment, and care. By combining their expertise, the Coalition and NICRAT are committed to accelerating solutions and enhancing the quality of life for women affected by these diseases. This partnership exemplifies their shared commitment to impactful, inclusive healthcare initiatives, striving to make a profound difference in communities across Nigeria. For more detailed information, please refer to the full press release.

Nigerian Health Leaders partner with Global Coalition on Ovarian Cancer Initiatives

Ovarian Cancer Cost-of-Illness Study

The World Ovarian Cancer Coalition’s Ovarian Cancer Cost-of-Illness Study is the first comprehensive assessment of the social and economic burden of ovarian cancer across 11 countries. This groundbreaking study quantifies the disease’s costs and outlines necessary actions to improve survival and quality of life for patients and caregivers. Utilizing a prevalence-based cost-of-illness approach and leveraging data from previous Coalition studies, this research aims to influence policy decisions and advocate for prioritizing ovarian cancer globally. The study’s abstract has been accepted for presentation at the UICC’s World Cancer Congress in Geneva, with full publication expected later in 2024.

Cost of Illness Study

World Ovarian Cancer Day Impact

Since 2013, the global ovarian cancer community has come together every 8 May on World Ovarian Cancer Day. An initiative of the World Ovarian Cancer Coalition, the campaign theme for the past three years has been “No Woman Left Behind”. From humble beginnings, the campaign grows year on year and in 2023 captured the attention of Oscar Award Winning Actress Angelina Jolie. People from 186 countries and speaking 54 languages took part in the 2024 campaign in some way, reflecting World Ovarian Cancer Day’s transformation from a grassroots initiative into a global movement.

The 2024 Impact Report can be found here:


Press Releases

This section provides access to the latest press releases from the World Ovarian Cancer Coalition, supporting our application for the prestigious .ORG Impact Award. Here, you will find important announcements, strategic partnerships, groundbreaking studies, and significant milestones that demonstrate our ongoing commitment to driving equitable change and improving the lives of those affected by ovarian cancer worldwide. These press releases highlight our efforts and impact, underscoring our dedication to making a profound difference in the fight against ovarian cancer. Our latest press release is below, whilst you can find all of our releases here.

World Ovarian Cancer Coalition Unveils Groundbreaking Global Study to Transform Ovarian Cancer Care in Low- and Middle-Income Countries